Acupuncture along with glaucoma drops for mild or moderate glaucoma
Part of Eyes & vision clinical trials.
This trial studies whether adding acupuncture to your usual glaucoma medication can help with glaucoma control in people with mild or moderate primary open-angle glaucoma. It compares acupuncture plus treatment versus treatment alone (randomly assigned).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary open-angle glaucoma for at least 3 months
- Your glaucoma is mild or moderate
- You’re age 20 or older
- You use 1 or 2 glaucoma medicines
- You agree to take part and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a laser treatment called selective laser trabeculoplasty works in people with open-angle glaucoma. It looks at results over 12 months to see if it helps lower eye pressure.
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
This study measures how eye pressure and standard eye-function tests perform in people with normal eyes, higher eye pressure, or early signs of glaucoma. It may help researchers understand who is at risk and how best to monitor eye health before or during glaucoma.
This trial tests whether gentle electrical stimulation can help improve vision in people with moderate vision loss from glaucoma. It might offer a new way to strengthen remaining vision.
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.